{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:36:26Z","timestamp":1792985786994,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,6,25]],"date-time":"2016-06-25T00:00:00Z","timestamp":1466812800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan (TW)","doi-asserted-by":"publisher","award":["MOST 103-2320-B-038-048"],"award-info":[{"award-number":["MOST 103-2320-B-038-048"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chi Mei Medical Center, Taiwan (TW)","award":["99CM-TMU-01-4"],"award-info":[{"award-number":["99CM-TMU-01-4"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s10495-016-1264-z","type":"journal-article","created":{"date-parts":[[2016,6,25]],"date-time":"2016-06-25T08:21:58Z","timestamp":1466842918000},"page":"1008-1018","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A novel tubulin polymerization inhibitor, MPT0B206, downregulates Bcr-Abl expression and induces apoptosis in imatinib-sensitive and imatinib-resistant CML cells"],"prefix":"10.1007","volume":"21","author":[{"given":"Chih-Wei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueh-Lun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Ping","family":"Liou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hsiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsai-Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huei-Mei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,25]]},"reference":[{"key":"1264_CR1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1126\/science.3460176","volume":"233","author":"Y Ben-Neriah","year":"1986","unstructured":"Ben-Neriah Y, Daley GQ, Mes-Masson AM, Witte ON, Baltimore D (1986) The chronic myelogenous leukemia-specific P210 protein is the product of the bcr-abl hybrid gene. Science 233:212\u2013216","journal-title":"Science"},{"key":"1264_CR2","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1182\/blood-2003-12-4111","volume":"103","author":"B Calabretta","year":"2004","unstructured":"Calabretta B, Perrotti D (2004) The biology of CML blast crisis. Blood 103:4010\u20134022","journal-title":"Blood"},{"key":"1264_CR3","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","volume":"293","author":"ME Gorre","year":"2001","unstructured":"Gorre ME, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao PN, Sawyers CL (2001) Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 293:876\u2013880","journal-title":"Science"},{"key":"1264_CR4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1182\/asheducation-2005.1.183","volume":"1","author":"NP Shah","year":"2005","unstructured":"Shah NP (2005) Loss of response to imatinib: mechanisms and management. Hematology Am Soc Hematol Educ Program 1:183\u2013187","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"1264_CR5","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.leukres.2007.11.008","volume":"32","author":"Y Deguchi","year":"2008","unstructured":"Deguchi Y, Kimura S, Ashihara E, Niwa T, Hodohara K, Fujiyama Y, Maekawa T (2008) Comparison of imatinib, dasatinib, nilotinib and INNO-406 in imatinib-resistant cell lines. Leuk Res 32:980\u2013983","journal-title":"Leuk Res"},{"key":"1264_CR6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrm2369","volume":"9","author":"A Akhmanova","year":"2008","unstructured":"Akhmanova A, Steinmetz MO (2008) Tracking the ends: a dynamic protein network controls the fate of microtubule tips. Nat Rev Mol Cell Biol 9:309\u2013322","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1264_CR7","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.4161\/cc.6.12.4361","volume":"6","author":"F Wolf","year":"2007","unstructured":"Wolf F, Sigl R, Geley S (2007) \u2018\u2026 The end of the beginning\u2019: cdk1 thresholds and exit from mitosis. Cell Cycle 6:1408\u20131411","journal-title":"Cell Cycle"},{"key":"1264_CR8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0955-0674(96)80080-9","volume":"8","author":"DJ Lew","year":"1996","unstructured":"Lew DJ, Kornbluth S (1996) Regulatory roles of cyclin dependent kinase phosphorylation in cell cycle control. Curr Opin Cell Biol 8:795\u2013804","journal-title":"Curr Opin Cell Biol"},{"key":"1264_CR9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000040822","volume":"99","author":"R Munker","year":"1998","unstructured":"Munker R, Kantarjian H, O\u2019Brien S, Keating M, Andreeff M, Estey EH (1998) Phase I study of paclitaxel in refractory acute myelogenous leukemias using a weekly schedule. Acta Haematol 99:106\u2013108","journal-title":"Acta Haematol"},{"key":"1264_CR10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1634\/theoncologist.9-suppl_2-24","volume":"9","author":"J Crown","year":"2004","unstructured":"Crown J, O\u2019Leary M, Ooi WS (2004) Docetaxel and paclitaxel in the treatment of breast cancer: a review of clinical experience. Oncologist 9:24\u201332","journal-title":"Oncologist"},{"key":"1264_CR11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nrc2049","volume":"7","author":"JR Jackson","year":"2007","unstructured":"Jackson JR, Patrick DR, Dar MM, Huang PS (2007) Targeted anti-mitotic therapies: can we improve on tubulin agents? Nat Rev Cancer 7:107\u2013117","journal-title":"Nat Rev Cancer"},{"key":"1264_CR12","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1525-1438.2007.01185.x","volume":"18","author":"S Yeasmin","year":"2008","unstructured":"Yeasmin S, Nakayama K, Ishibashi M, Oride A, Katagiri A, Purwana IN, Iida K, Nakayama N, Ishikura H, Miyazaki K (2008) Therapy-related myelodysplasia and acute myeloid leukemia following paclitaxel- and carboplatin-based chemotherapy in an ovarian cancer patient: a case report and literature review. Int J Gynecol Cancer 18:1371\u20131376","journal-title":"Int J Gynecol Cancer"},{"key":"1264_CR13","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1021\/jm070557q","volume":"50","author":"JP Liou","year":"2007","unstructured":"Liou JP, Wu CY, Hsieh HP, Chang CY, Chen CM, Kuo CC, Chang JY (2007) 4- and 5-aroylindoles as novel classes of potent antitubulin agents. J Med Chem 50:4548\u20134552","journal-title":"J Med Chem"},{"key":"1264_CR14","doi-asserted-by":"crossref","first-page":"C37","DOI":"10.1152\/ajpcell.00130.2013","volume":"306","author":"YW Huang","year":"2014","unstructured":"Huang YW, Lee WH, Tsai YH, Huang HM (2014) Activin A induction of erythroid differentiation sensitizes K562 chronic myeloid leukemia cells to a subtoxic concentration of imatinib. Am J Physiol Cell Physiol 306:C37\u2013C44","journal-title":"Am J Physiol Cell Physiol"},{"key":"1264_CR15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000351852","volume":"92","author":"WH Lee","year":"2013","unstructured":"Lee WH, Liu HE, Chang JY, Liou JP, Huang HM (2013) MPT0B169, a new tubulin inhibitor, inhibits cell growth and induces G2\/M arrest in nonresistant and paclitaxel-resistant cancer cells. Pharmacology 92:90\u201398","journal-title":"Pharmacology"},{"key":"1264_CR16","first-page":"5995","volume":"62","author":"C Ricci","year":"2002","unstructured":"Ricci C, Scappini B, Divoky V, Gatto S, Onida F, Verstovsek S, Kantarjian HM, Beran M (2002) Mutation in the ATP-binding pocket of the ABL kinase domain in an STI571-resistant BCR\/ABL-positive cell line. Cancer Res 62:5995\u20135998","journal-title":"Cancer Res"},{"key":"1264_CR17","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S1470-2045(07)70342-X","volume":"8","author":"JF Apperley","year":"2007","unstructured":"Apperley JF (2007) Part I: mechanisms of resistance to imatinib in chronic myeloid leukaemia. Lancet Oncol 8:1018\u20131029","journal-title":"Lancet Oncol"},{"key":"1264_CR18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/leu.2010.238","volume":"25","author":"D Bixby","year":"2011","unstructured":"Bixby D, Talpaz M (2011) Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia. Leukemia 25:7\u201322","journal-title":"Leukemia"},{"key":"1264_CR19","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1006\/jsbi.2000.4254","volume":"129","author":"JD Robertson","year":"2000","unstructured":"Robertson JD, Orrenius S, Zhivotovsky B (2000) Review: nuclear events in apoptosis. J Struct Biol 129:346\u2013358","journal-title":"J Struct Biol"},{"key":"1264_CR20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc1317","volume":"4","author":"MA Jordan","year":"2004","unstructured":"Jordan MA, Wilson L (2004) Microtubules as a target for anticancer drugs. Nat Rev Cancer 4:253\u2013265","journal-title":"Nat Rev Cancer"},{"key":"1264_CR21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev.bi.61.070192.002301","volume":"61","author":"C Norbury","year":"1992","unstructured":"Norbury C, Nurse P (1992) Animal cell cycles and their control. Annu Rev Biochem 61:441\u2013470","journal-title":"Annu Rev Biochem"},{"key":"1264_CR22","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/0955-0674(94)90060-4","volume":"6","author":"TR Coleman","year":"1994","unstructured":"Coleman TR, Dunphy WG (1994) Cdc2 regulatory factors. Curr Opin Cell Biol 6:877\u2013882","journal-title":"Curr Opin Cell Biol"},{"key":"1264_CR23","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0955-0674(97)80081-6","volume":"9","author":"PK Sorger","year":"1997","unstructured":"Sorger PK, Dobles M, Tournebize R, Hyman AA (1997) Coupling cell division and cell death to microtubule dynamics. Curr Opin Cell Biol 9:807\u2013814","journal-title":"Curr Opin Cell Biol"},{"key":"1264_CR24","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood-2012-05-431379","volume":"121","author":"JS Khorashad","year":"2013","unstructured":"Khorashad JS, Kelley TW, Szankasi P, Mason CC, Soverini S, Adrian LT, Eide CA, Zabriskie MS, Lange T, Estrada JC, Pomicter AD, Eiring AM, Kraft IL, Anderson DJ, Gu Z, Alikian M, Reid AG, Foroni L, Marin D, Druker BJ, O\u2019Hare T, Deininger MW (2013) BCR-ABL1 compound mutations in tyrosine kinase inhibitor\u2013resistant CML: frequency and clonal relationships. Blood 121:489\u2013498","journal-title":"Blood"},{"key":"1264_CR25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10147-013-0641-7","volume":"19","author":"S Kimura","year":"2014","unstructured":"Kimura S, Ando T, Kojima K (2014) Ever-advancing chronic myeloid leukemia treatment. Int J Clin Oncol 19:3\u20139","journal-title":"Int J Clin Oncol"},{"key":"1264_CR26","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1093\/emboj\/16.20.6151","volume":"16","author":"T Skorski","year":"1997","unstructured":"Skorski T, Bellacosa A, Nieborowska-Skorska M, Majewski M, Martinez R, Choi JK, Trotta R, Wlodarski P, Perrotti D, Chan TO, Wasik MA, Tsichlis PN, Calabretta B (1997) Transformation of hematopoietic cells by BCR\/ABL requires activation of a PI-3k\/Akt-dependent pathway. EMBO J 16:6151\u20136161","journal-title":"EMBO J"},{"key":"1264_CR27","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1182\/blood.V95.6.2118","volume":"95","author":"C Sillaber","year":"2000","unstructured":"Sillaber C, Gesbert F, Frank DA, Sattler M, Griffin JD (2000) STAT5 activation contributes to growth and viability in Bcr\/Abl-transformed cells. Blood 95:2118\u20132125","journal-title":"Blood"},{"key":"1264_CR28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.leu.2403241","volume":"18","author":"LS Steelman","year":"2004","unstructured":"Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE, McCubrey JA (2004) JAK\/STAT, Raf\/MEK\/ERK, PI3K\/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia 18:189\u2013218","journal-title":"Leukemia"},{"key":"1264_CR29","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/emmm.201000062","volume":"2","author":"A Hoelbl","year":"2010","unstructured":"Hoelbl A, Schuster C, Kovacic B, Zhu B, Wickre M, Hoelzl MA, Fajmann S, Grebien F, Warsch W, Stengl G, Hennighausen L, Poli V, Beug H, Moriggl R, Sexl V (2010) Stat5 is indispensable for the maintenance of bcr\/abl-positive leukaemia. EMBO Mol Med 2:98\u2013110","journal-title":"EMBO Mol Med"},{"key":"1264_CR30","doi-asserted-by":"crossref","first-page":"8804","DOI":"10.1038\/sj.onc.1206028","volume":"21","author":"M Huang","year":"2002","unstructured":"Huang M, Dorsey JF, Epling-Burnette PK, Nimmanapalli R, Landowski TH, Mora LB, Niu G, Sinibaldi D, Bai F, Kraker A, Yu H, Moscinski L, Wei L, Djeu J, Dalton WS, Bhalla K, Loughran TP, Wu J, Jove R (2002) Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells. Oncogene 21:8804\u20138816","journal-title":"Oncogene"},{"key":"1264_CR31","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1111\/j.1582-4934.2008.00549.x","volume":"13","author":"ZH Fang","year":"2009","unstructured":"Fang ZH, Dong CL, Chen Z, Zhou B, Liu N, Lan HF, Liang L, Liao WB, Zhang L, Han ZC (2009) Transcriptional regulation of surviving by c-Myc in BCR\/ABL-transformed cells: implications in anti-leukaemic strategy. J Cell Mol Med 13:2039\u20132052","journal-title":"J Cell Mol Med"},{"key":"1264_CR32","doi-asserted-by":"crossref","first-page":"e77390","DOI":"10.1371\/journal.pone.0077390","volume":"8","author":"O Bucur","year":"2013","unstructured":"Bucur O, Stancu AL, Goganau I, Petrescu SM, Pennarun B, Bertomeu T, Dewar R, Khosravi-Far R (2013) Combination of bortezomib and mitotic inhibitors down-modulate Bcr-Abl and efficiently eliminates tyrosine-kinase inhibitor sensitive and resistant Bcr-Abl-positive leukemic cells. PloS One 8:e77390","journal-title":"PloS One"},{"key":"1264_CR33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1158\/1078-0432.CCR-13-1063","volume":"20","author":"X Shi","year":"2014","unstructured":"Shi X, Chen X, Li X, Lan X, Zhao C, Liu S, Huang H, Liu N, Liao S, Song W, Zhou P, Wang S, Xu L, Wang X, Dou QP, Liu J (2014) Gambogic acid induces apoptosis in imatinib-resistant chronic myeloid leukemia cells via inducing proteasome inhibition and caspase-dependent Bcr-Abl downregulation. Clin Cancer Res 20:151\u2013163","journal-title":"Clin Cancer Res"},{"key":"1264_CR34","doi-asserted-by":"crossref","first-page":"20049","DOI":"10.1074\/jbc.274.29.20049","volume":"274","author":"BB Wolf","year":"1999","unstructured":"Wolf BB, Green DR (1999) Suicidal tendencies: apoptotic cell death by caspase family proteinases. J Biol Chem 274:20049\u201320052","journal-title":"J Biol Chem"},{"key":"1264_CR35","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3322\/canjclin.55.3.178","volume":"55","author":"IM Ghobrial","year":"2005","unstructured":"Ghobrial IM, Witzig TE, Adjei AA (2005) Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 55:178\u2013194","journal-title":"CA Cancer J Clin"},{"key":"1264_CR36","doi-asserted-by":"crossref","first-page":"34227","DOI":"10.1074\/jbc.M402290200","volume":"279","author":"Y Dai","year":"2004","unstructured":"Dai Y, Rahmani M, Corey SJ, Dent P, Grant S (2004) A Bcr\/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2. J Biol Chem 279:34227\u201334239","journal-title":"J Biol Chem"},{"key":"1264_CR37","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s00018-010-0285-y","volume":"67","author":"LA Pradelli","year":"2010","unstructured":"Pradelli LA, B\u00e9n\u00e9teau M, Ricci JE (2010) Mitochondrial control of caspase-dependent and -independent cell death. Cell Mol Life Sci 67:1589\u20131597","journal-title":"Cell Mol Life Sci"}],"updated-by":[{"DOI":"10.1007\/s10495-017-1403-1","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T00:00:00Z","timestamp":1503014400000}}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-016-1264-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10495-016-1264-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-016-1264-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T22:12:58Z","timestamp":1600812778000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10495-016-1264-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,25]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["1264"],"URL":"https:\/\/doi.org\/10.1007\/s10495-016-1264-z","relation":{"erratum":[{"id-type":"doi","id":"10.1007\/s10495-017-1403-1","asserted-by":"object"}]},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,25]]}}}